These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29412103)

  • 1. Nanotechnology Inspired Advanced Engineering Fundamentals for Optimizing Drug Delivery.
    Kassem AA
    Curr Drug Targets; 2018; 19(15):1839-1854. PubMed ID: 29412103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired Platform Conjugated Active Drug Delivery.
    Shao J; Xuan M; He Q; Dai L
    Curr Drug Targets; 2018 Feb; 19(4):328-338. PubMed ID: 27262485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured materials for applications in drug delivery and tissue engineering.
    Goldberg M; Langer R; Jia X
    J Biomater Sci Polym Ed; 2007; 18(3):241-68. PubMed ID: 17471764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-targeted theranostic nanomedicines against cancer.
    Yao VJ; D'Angelo S; Butler KS; Theron C; Smith TL; Marchiò S; Gelovani JG; Sidman RL; Dobroff AS; Brinker CJ; Bradbury ARM; Arap W; Pasqualini R
    J Control Release; 2016 Oct; 240():267-286. PubMed ID: 26772878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.
    Parveen S; Sahoo SK
    Clin Pharmacokinet; 2006; 45(10):965-88. PubMed ID: 16984211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach.
    Hamidi M; Azadi A; Rafiei P; Ashrafi H
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):435-67. PubMed ID: 24099328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability: issues and solutions via nanoformulations.
    Pathak K; Raghuvanshi S
    Clin Pharmacokinet; 2015 Apr; 54(4):325-57. PubMed ID: 25666353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated nanomedicines: recent progress and remaining concerns.
    Vllasaliu D; Fowler R; Stolnik S
    Expert Opin Drug Deliv; 2014 Jan; 11(1):139-54. PubMed ID: 24295065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-encapsulated camouflaged nanomedicines in drug delivery.
    Ghosh S; Girigoswami K; Girigoswami A
    Nanomedicine (Lond); 2019 Aug; 14(15):2067-2082. PubMed ID: 31355709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional DNA Origami Nanoplatforms for Drug Delivery.
    Lu X; Liu J; Wu X; Ding B
    Chem Asian J; 2019 Jul; 14(13):2193-2202. PubMed ID: 31125182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
    Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
    Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
    Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
    Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.